Roche is set to expand its coagulation testing product by developing a full line of coagulation analyzers for hospital and reference laboratories in North America.
Subscribe to our email newsletter
Roche said the newly developed analyzers will be marketed under Roche’s cobas brand and will include three platforms which will address a range of customer needs, from low-volume testing to the high-throughput demands of commercial laboratories, along with a complete menu of coagulation assays.
Roche Diagnostics and Diagnostica Stago will receive separate paths in laboratory coagulation in territories where Roche distributes the Stago line of lab coagulation analyzers.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.